This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Novobiotic Pharmaceuticals, LLC. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Ashley Zullo
Introduction
Ashley Zullo is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly through her work on novel depsipeptides. With a total of two patents to her name, Zullo is recognized for her innovative approaches to treating various disorders.
Latest Patents
Zullo's latest patents focus on the development and application of depsipeptides. The first patent details the preparation of these novel depsipeptides and their pharmaceutical compositions. It also outlines methods for using these depsipeptides to treat or inhibit various disorders. The second patent reiterates similar themes, emphasizing the importance of these compounds in medical applications.
Career Highlights
Ashley Zullo is currently employed at Novobiotic Pharmaceuticals, LLC, where she continues to advance her research and development efforts. Her work is pivotal in the exploration of new therapeutic options, showcasing her dedication to improving healthcare outcomes.
Collaborations
Zullo collaborates with notable colleagues, including Dallas E Hughes and Amy Spoering. These partnerships enhance her research capabilities and contribute to the innovative environment at Novobiotic Pharmaceuticals.
Conclusion
Ashley Zullo's contributions to the field of pharmaceutical sciences through her patents on depsipeptides highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for future medical treatments.